Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine Cyanobacterium Symploca sp
about
Discovery of natural product anticancer agents from biodiverse organismsChemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discoveryTiny Microbes with a Big Impact: The Role of Cyanobacteria and Their Metabolites in Shaping Our FutureBioactive Compounds Isolated from Microalgae in Chronic Inflammation and CancerMarine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosisPotent Elastase Inhibitors from Cyanobacteria: Structural Basis and Mechanisms Mediating Cytoprotective and Anti-Inflammatory Effects in Bronchial Epithelial CellsAntitumor peptides from marine organismsPhylogenetic and chemical diversity of three chemotypes of bloom-forming lyngbya species (Cyanobacteria: Oscillatoriales) from reefs of southeastern FloridaUncovering Potential Applications of Cyanobacteria and Algal Metabolites in Biology, Agriculture and Medicine: Current Status and Future Prospects.The structural diversity and promise of antiparasitic marine invertebrate-derived small moleculesScytonemides A and B, cyclic peptides with 20S proteasome inhibitory activity from the cultured cyanobacterium Scytonema hofmanii.New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past DecadeCyanobacteria: an emerging source for drug discovery.Intramolecular modulation of serine protease inhibitor activity in a marine cyanobacterium with antifeedant properties.Stigonemapeptin, an Ahp-containing depsipeptide with elastase inhibitory activity from the bloom-forming freshwater cyanobacterium Stigonema sp.Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds."Head-to-side-chain" cyclodepsipeptides of marine origin.Antineoplastic agents. 570. Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris.The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites.Cyanobacteria: potential candidates for drug discovery.Secondary metabolites from marine-derived microorganisms.From crystal to compound: structure-based antimalarial drug discovery.Macrocycles as potential therapeutic agents in neglected diseases.Chemopreventive role of food-derived proteins and peptides: A review.Integrating Molecular Networking and Biological Assays To Target the Isolation of a Cytotoxic Cyclic Octapeptide, Samoamide A, from an American Samoan Marine Cyanobacterium.Structural Characterization of New Peptide Variants Produced by Cyanobacteria from the Brazilian Atlantic Coastal Forest Using Liquid Chromatography Coupled to Quadrupole Time-of-Flight Tandem Mass Spectrometry.New prenylated aeruginosin, microphycin, anabaenopeptin and micropeptin analogues from a Microcystis bloom material collected in Kibbutz Kfar Blum, Israel.Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer.Interpretation of tandem mass spectra obtained from cyclic nonribosomal peptides.Tailored Ahp-cyclodepsipeptides as Potent Non-covalent Serine Protease Inhibitors.Ahp cyclodepsipeptides: the impact of the Ahp residue on the "canonical inhibition" of S1 serine proteases.Adsorbable organic bromine compounds (AOBr) in aquatic samples: a nematode-based toxicogenomic assessment of the exposure hazard.Two organobromines trigger lifespan, growth, reproductive and transcriptional changes in Caenorhabditis elegans.Therapeutic Properties and Biological Benefits of Marine-Derived Anticancer Peptides.Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.Development of a Solid-Phase Approach to the Natural Product Class of Ahp-Containing CyclodepsipeptidesMarine Peptides and Proteins with Cytotoxic and Antitumoral Properties
P2860
Q24605488-3A637ECC-47D2-4765-B556-323D43994B67Q24623272-E3B81B3F-4FB3-4EA4-BF17-7D3B11D2CE84Q26747668-047AEA92-6910-4C02-A3F6-993CE28E1002Q26782065-28446A7B-76D4-4751-A9D3-49B7DBC872BCQ27021618-2CA83B21-0497-49C7-B810-B63B3BEF5A4AQ27675999-13AC0E24-C54D-4341-B39B-C684DB01D115Q31040702-AB28F4BC-E11E-40BE-A89C-A6DA32CEA8C9Q33415921-F9C4699F-946B-4B8B-99CB-73788B568A9EQ33600275-643624FC-8CC5-4FE3-8459-4D254D057C24Q33721639-8234FE70-10CF-42A0-9610-3FE9067914CBQ33740964-AB6BEE7E-D6F2-4E04-9C7B-257A84D07DA7Q33744123-EE512CC3-FCB3-470F-BE6C-F8F08843047EQ33863512-F73128DC-B6F4-4BCE-BE80-329E32B53405Q33983799-866F650B-5F9C-4B8A-B1DA-7971483041B8Q34223966-9DF7B012-4A77-4445-8E21-80407B3F41B1Q36253534-6D97895C-631A-437D-852A-A8078F0E5123Q36999172-09B78AB7-3AC2-48FC-BE69-479D2E5A6741Q37395652-2EEE7247-435B-4832-801E-6FE7FCDDAA6AQ37598633-75BD8090-8548-4556-B15B-DC3AAB96C413Q37930568-BF0E19DB-59E5-45D7-AD43-E215AB82E87EQ38093448-089C671E-EC62-4A04-BC18-17D9907E9C30Q38161569-9DAD00E9-D50A-443B-9C50-52EF368321C8Q38227796-DDC65ECD-EC46-4E2A-BA4B-2A314D60FD47Q38343825-A85D7C89-1B47-4052-AD97-5C47601958E0Q38632533-C2D8CB3B-E8DC-4E29-A317-952660CB2062Q39038608-5D0B251A-BFD3-4782-BF23-3867CE7F51F0Q39430614-488F59D1-0808-4928-9B2F-5F84B240E102Q40036280-A74CA936-4106-49F3-A988-42D42CB45515Q41661853-03A0F199-CFFA-48D7-8997-5C978364FED3Q41889971-B416D696-A1FB-484D-B3A8-2FDE65B36697Q48131629-E01B3923-A986-4EDF-AE89-B62A682FBEFCQ50883904-789F422E-D401-46A7-B195-492F7588D924Q51354843-4B78B1F6-3B31-4FE8-94DB-8EDDFCCD1376Q51444288-38F15EB5-DAFC-4AC8-BD50-6E4E84AA29E3Q52646693-EB9FC195-801F-4BC6-9B38-DE7172A83C94Q53094795-B7F02A06-592C-4A06-BB47-25803BC232B7Q57833371-D6E90D07-EAB6-40FB-AA25-08721A53D67AQ58035054-B88F3B93-2F53-4CD2-9C19-43EE297601D8
P2860
Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine Cyanobacterium Symploca sp
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Symplocamide A, a potent cytot ...... ine Cyanobacterium Symploca sp
@ast
Symplocamide A, a potent cytot ...... ine Cyanobacterium Symploca sp
@en
Symplocamide A, a potent cytot ...... ine Cyanobacterium Symploca sp
@nl
type
label
Symplocamide A, a potent cytot ...... ine Cyanobacterium Symploca sp
@ast
Symplocamide A, a potent cytot ...... ine Cyanobacterium Symploca sp
@en
Symplocamide A, a potent cytot ...... ine Cyanobacterium Symploca sp
@nl
prefLabel
Symplocamide A, a potent cytot ...... ine Cyanobacterium Symploca sp
@ast
Symplocamide A, a potent cytot ...... ine Cyanobacterium Symploca sp
@en
Symplocamide A, a potent cytot ...... ine Cyanobacterium Symploca sp
@nl
P2093
P2860
P3181
P356
P1476
Symplocamide A, a potent cytot ...... ine Cyanobacterium Symploca sp
@en
P2093
Cynthia F Shuman
Daniel J Edwards
Teatulohi Matainaho
William H Gerwick
P2860
P3181
P356
10.1021/NP070280X
P407
P577
2007-12-29T00:00:00Z